Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort

 

 Buy Article Permissions and Reprints

Abstract

The T54 variant of the FABP2 gene has shown an association with the insulin resistance syndrome in some, but not all, studies. Here, we tested the hypothesis that the association between FABP2 A54T genotype and type 2 diabetes (T2DM) is confounded by body mass index (BMI) and is different between the two genders. 192 incident cases of T2DM and 384 sex- and age-matched controls were taken from the EPIC-Potsdam study cohort. Logistic regression analyses revealed that BMI was a strong confounder for diabetes risk association among women. When adjusted for BMI, the homozygous T54 variant was significantly associated with reduced risk of T2DM in women (OR = 0.24, 95 %CI: 0.07 - 0.82), but not in men in the co-dominant inheritance model. Accordingly, HbA_1c values were significantly lower in women carrying two T54 alleles with BMI regarded as covariate. While accounting for potentially confounding effects, linear trends of increased BMI and leptin values were observed in women according to the presence of T54 alleles. The interaction term (p = 0.04) of continuous BMI and T54-coding genotypes suggested that the T54 variant is an effect-modifier for BMI in females. We conclude that the T54 allele of FABP2 A54T is associated both with higher BMI and reduced risk of T2DM in women from the German EPIC-Potsdam study.

References

• 1 Baier L J, Bogardus C, Sacchettini J C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells.  J Biol Chem. 1996;  271 10 892-10 896
  PubMedGoogle Scholar
• 2 Agren J J, Vidgren H M, Valve R S, Laakso M, Uusitupa M I. Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene.  Am J Clin Nutr. 2001;  73 31-35
  PubMedGoogle Scholar
• 3 Pratley R E, Baier L, Pan D A, Salbe A D, Storlien L, Ravussin E, Bogardus C. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans.  J Lipid Res. 2000;  41 2002-2008
  PubMedGoogle Scholar
• 4 Weiss E P, Brown M D, Shuldiner A R, Hagberg J M. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects.  Physiol Genomics. 2002;  10 145-157
  PubMedGoogle Scholar
• 5 Duarte N L, Colagiuri S, Palu T, Wang X L, Wilcken D E. Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population.  Mol Genet Metab. 2003;  79 183-188
  CrossrefPubMedGoogle Scholar
• 6 Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans.  Diabetes Obes Metab. 2004;  6 45-49
  CrossrefPubMedGoogle Scholar
• 7 Lara-Castro C, Hunter G R, Lovejoy J C, Gower B A, Fernandez J R. Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women.  J Clin Endocrinol Metab. 2005;  90 1196-1201
  PubMedGoogle Scholar
• 8 Stan S, Lambert M, Delvin E, Paradis G, O’Loughlin J, Hanley J A, Levy E. Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth.  J Lipid Res. 2005;  46 320-327
  PubMedGoogle Scholar
• 9 Takakura Y, Yoshioka K, Umekawa T, Kogure A, Toda H, Yoshikawa T, Yoshida T. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity.  Diabetes Res Clin Pract. 2005;  67 36-42
  CrossrefPubMedGoogle Scholar
• 10 Hegele R A, Harris S B, Hanley A J, Sadikian S, Connelly P W, Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians.  J Clin Endocrinol Metab. 1996;  81 4334-4337
  CrossrefPubMedGoogle Scholar
• 11 Pollex R L, Hanley A J, Zinman B, Harris S B, Khan H M, Hegele R A. Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations.  Atherosclerosis. 2006;  184 121-129
  CrossrefPubMedGoogle Scholar
• 12 Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects.  J Clin Endocrinol Metab. 1997;  82 2629-2632
  CrossrefPubMedGoogle Scholar
• 13 Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, Masana L, Ehnholm C. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants.  Atherosclerosis. 2000;  152 317-325
  CrossrefPubMedGoogle Scholar
• 14 Endo K, Yanagi H, Hirano C, Hayakawa Y, Hamaguchi H, Tomura S. No association found between the Ala54Thr polymorphism of FABP2 gene and obesity and obesity with dyslipidemia in Japanese schoolchildren.  J Atheroscler Thromb. 2001;  8 80-83
  PubMedGoogle Scholar
• 15 Erkkila A T, Lindi V, Lehto S, Pyorala K, Laakso M, Uusitupa M I. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.  Nutr Metab Cardiovasc Dis. 2002;  12 53-59
  PubMedGoogle Scholar
• 16 Albala C, Santos J L, Cifuentes M, Villarroel A C, Lera L, Liberman C, Angel B, Perez-Bravo F. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women.  Obes Res. 2004;  12 340-345
  PubMedGoogle Scholar
• 17 Vassileva G, Huwyler L, Poirier K, Agellon L B, Toth M J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice.  Faseb J. 2000;  14 2040-2046
  CrossrefPubMedGoogle Scholar
• 18 Boeing H, Korfmann A, Bergmann M M. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition.  Ann Nutr Metab. 1999;  43 205-215
  PubMedGoogle Scholar
• 19 Bergmann M M, Bussas U, Boeing H. Follow-up procedures in EPIC-Germany - data quality aspects. European Prospective Investigation into Cancer and Nutrition.  Ann Nutr Metab. 1999;  43 225-234
  CrossrefPubMedGoogle Scholar
• 20 Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann M M, Ristow M, Boeing H, Pfeiffer A F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.  Diabetes. 2003;  52 812-817
  CrossrefPubMedGoogle Scholar
• 21 Galluzzi J R, Cupples L A, Meigs J B, Wilson P W, Schaefer E J, Ordovas J M. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study.  Diabetes Care. 2001;  24 1161-1166
  PubMedGoogle Scholar
• 22 Baier L J, Sacchettini J C, Knowler W C, Eads J, Paolisso G, Tataranni P A, Mochizuki H, Bennett P H, Bogardus C, Prochazka M. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.  J Clin Invest. 1995;  95 1281-1287
  PubMedGoogle Scholar
• 23 Lei H H, Coresh J, Shuldiner A R, Boerwinkle E, Brancati F L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.  Diabetes. 1999;  48 1868-1872
  PubMedGoogle Scholar

Dr. phil. nat. Eva Fisher

Department of Epidemiology

German Institute of Human Nutrition Potsdam-Rehbruecke · Arthur-Scheunert-Allee 114 - 116 · 14558 Nuthetal · Germany

Fax: +49 (33200) 88 721 ·

Email: fisher@mail.dife.de